Cite
miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
MLA
Zhang, Jun-Jie, et al. “MiR-98 Inhibits Hepatocellular Carcinoma Cell Proliferation via Targeting EZH2 and Suppressing Wnt/β-Catenin Signaling Pathway.” Biomedicine & Pharmacotherapy, vol. 85, Jan. 2017, pp. 472–78. EBSCOhost, https://doi.org/10.1016/j.biopha.2016.11.053.
APA
Zhang, J.-J., Chen, J.-T., Hua, L., Yao, K.-H., & Wang, C.-Y. (2017). miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Biomedicine & Pharmacotherapy, 85, 472–478. https://doi.org/10.1016/j.biopha.2016.11.053
Chicago
Zhang, Jun-Jie, Jiang-Tao Chen, Long Hua, Kun-Hou Yao, and Chen-Yu Wang. 2017. “MiR-98 Inhibits Hepatocellular Carcinoma Cell Proliferation via Targeting EZH2 and Suppressing Wnt/β-Catenin Signaling Pathway.” Biomedicine & Pharmacotherapy 85 (January): 472–78. doi:10.1016/j.biopha.2016.11.053.